GlassScriptPhysician profile
Sara A Rothe
NPI 1144797366
$5,133.69
in general payments reported to CMS, 2019-2025
26 companies · $1,584 in 2025
The $1,584 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $359 · 2022: $677 · 2023: $1,165 · 2024: $1,349 · 2025: $1,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,097.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $463.72 | 2022-2025 | Verquvo, Winrevair |
| Abbott Laboratories | $420.13 | 2023-2025 | Eterna, Diamondback Coronary, Mitraclip |
| Astrazeneca Pharmaceuticals LP | $412.80 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Novartis Pharmaceuticals Corporation | $367.43 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $335.77 | 2023-2025 | Lifevest |
| Boston Scientific Corporation | $321.05 | 2021-2025 | Watchman, Watchman Flx |
| Amgen INC. | $284.92 | 2025 | Krystexxa, Repatha |
| Pfizer INC. | $284.10 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.75 | 2023-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $250.71 | 2021-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $249.12 | 2025 | Assure Wcd |
| Inspire Medical Systems, INC. | $205.86 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $192.44 | 2023-2025 | Camzyos, Eliquis |
| Cvrx, INC. | $191.11 | 2024 | Barostim Neo System |
| Atricure, INC. | $148.80 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $142.25 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Medtronic, INC. | $107.10 | 2022 | |
| Scpharmaceuticals INC. | $105.49 | 2024 | |
| Esperion Therapeutics, INC. | $102.27 | 2021 | |
| Zoll Circulation INC | $68.45 | 2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Lilly USA, LLC | $45.34 | 2021 | |
| Novo Nordisk INC | $42.31 | 2021-2025 | Rybelsus, Ozempic |
| Rhythm Pharmaceuticals, INC. | $33.13 | 2025 | Imcivree |
| Baxter Healthcare | $30.39 | 2025 | Perclot |
| Impulse Dynamics (USA) INC. | $29.36 | 2023 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $17.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Rothe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.